Literature DB >> 18660677

Adenosine and renal tubular function.

Francesca Di Sole1.   

Abstract

PURPOSE OF REVIEW: Intrarenal adenosine is present in the cytoplasm of renal epithelial cells and in the extracellular space. Adenosine is generated at high levels in response to imbalance between energy demand and supply (e.g. increased tubular sodium chloride transport or hypoxia) and activates cell membrane adenosine receptors to affect renal vascular and tubular functions. Adenosine regulates renal sodium and water excretion via a myriad of effects on renal hemodynamic, glomerular filtration rate, renin secretion and direct effects on the renal tubule epithelium. This review examines the direct effects of adenosine on renal tubular epithelial transport in light of the most recent evidence and discusses some physiologic and pathophysiologic implications. RECENT
FINDINGS: Intrarenal adenosine affects proximal fluid and solute transport in a biphasic fashion. Under physiological conditions adenosine stimulates proximal tubular re-absorption, thus reducing the load delivered to the distal nephron. A supra-physiologic increase in adenosine such as in ischemia reduces reabsorption in the proximal tubule, thus reducing renal oxygen consumption.
SUMMARY: Intrarenal adenosine and its receptors have important regulatory functions in the renal epithelium. A complete understanding of this autocrine/paracrine system holds great potential for novel therapeutic strategies, such as the use of nucleoside analogues for reno-protection in renal ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18660677     DOI: 10.1097/MNH.0b013e32830321e1

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  10 in total

Review 1.  Calcineurin homologous protein: a multifunctional Ca2+-binding protein family.

Authors:  Francesca Di Sole; Komal Vadnagara; Orson W Moe; Victor Babich
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-21

Review 2.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 3.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

4.  Adenine acts in the kidney as a signaling factor and causes salt- and water-losing nephropathy: early mechanism of adenine-induced renal injury.

Authors:  Ingrid F Dos Santos; Sulaiman Sheriff; Sihame Amlal; Rafeeq P H Ahmed; Charuhas V Thakar; Hassane Amlal
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-09

5.  Adenosine inhibits the basolateral Cl- ClC-K2/b channel in collecting duct intercalated cells.

Authors:  Oleg Zaika; Viktor N Tomilin; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

6.  Extracellular Adenosine Stimulates Vacuolar ATPase-Dependent Proton Secretion in Medullary Intercalated Cells.

Authors:  Maria A Battistone; Anil V Nair; Claire R Barton; Rachel N Liberman; Maria A Peralta; Diane E Capen; Dennis Brown; Sylvie Breton
Journal:  J Am Soc Nephrol       Date:  2017-12-08       Impact factor: 10.121

Review 7.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

8.  Adenosine activates a2b receptors and enhances chloride secretion in kidney inner medullary collecting duct cells.

Authors:  Madhumitha Rajagopal; Alan C Pao
Journal:  Hypertension       Date:  2010-03-22       Impact factor: 10.190

9.  Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate.

Authors:  E Peters; S Geraci; S Heemskerk; M J Wilmer; A Bilos; B Kraenzlin; N Gretz; P Pickkers; R Masereeuw
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

Review 10.  Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.

Authors:  Chien-An A Hu; Edward I Klopfer; Patricio E Ray
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.